Mushroom poisoning in infants and children: the Amanita pantherina/muscaria group.
The clinical features and management of nine cases of mushroom poisoning due to Amanita pantherina (eight cases) and Amanita muscaria (one case) admitted to a children's hospital are described. Most ingestions were in the toddler age group with males being more frequently involved. Symptoms occurred between 30-180 min with the onset of central nervous system depression, ataxia, waxing and waning obtundation, hallucinations, intermittent hysteria or hyperkinetic behavior. Vomiting was rare. Seizures or myoclonic twitching occurred in 4/9 patients, but was controlled with standard anticonvulsant therapy. No other anticholinergic or cholinergic signs were prominent. Recovery was rapid and complete in all patients.
Benjamin
D R
DR
Department of Laboratories, Children's Hospital and Medical Center, University of Washington, Seattle 98105.
D000293:Adolescent; D000367:Age Factors; D000545:Amanita; D002606:Charcoal / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005751:Gastric Lavage; D006801:Humans; D007223:Infant; D007486:Ipecac / Q000627:therapeutic use; D008297:Male; D009145:Mushroom Poisoning / Q000453:epidemiology* / Q000628:therapy; D010634:Phenobarbital / Q000627:therapeutic use; D012189:Retrospective Studies; D012737:Sex Factors; D014861:Washington / Q000453:epidemiology
D002606:Charcoal; D007486:Ipecac; D003975:Diazepam; D010634:Phenobarbital